SEC 13F Intelligence

Ecor1 Capital, LLC / RNAGBP

Ecor1 Capital, LLC’s Avidity Biosciences Inc Position

Does Ecor1 Capital, LLC own Avidity Biosciences Inc (RNAGBP)? Not currently — the last reported position was 765.0K shares worth $33M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$33M
Q3 2025
Shares
765.0K
% of Portfolio
+1.60%
Quarters Held
17
position exited

Position History RNAGBP

Reported value by quarter
Q2 ’20: $59MQ2 ’20Q3 ’20: $59MQ4 ’20: $54MQ1 ’21: $46MQ1 ’21Q2 ’21: $52MQ3 ’21: $68MQ4 ’21: $66MQ4 ’21Q1 ’22: $51MQ2 ’22: $40MQ3 ’22: $47MQ3 ’22Q1 ’24: $19MQ2 ’24: $31MQ3 ’24: $35MQ3 ’24Q4 ’24: $16MQ1 ’25: $16MQ2 ’25: $14MQ2 ’25Q3 ’25: $33Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025765.0K$33M+1.60%
Q2 2025500.0K$14M+0.84%
Q1 2025557.6K$16M+0.98%
Q4 2024557.6K$16M+0.61%
Q3 2024757.6K$35M+1.19%
Q2 2024757.6K$31M+0.95%
Q1 2024757.6K$19M+0.49%
Q3 20222.90M$47M+1.40%
Q2 20222.76M$40M+1.38%
Q1 20222.76M$51M+1.59%
Q4 20212.76M$66M+2.09%
Q3 20212.76M$68M+2.36%
Q2 20212.10M$52M+1.94%
Q1 20212.10M$46M+2.04%
Q4 20202.10M$54M+2.89%
Q3 20202.10M$59M+4.22%
Q2 20202.10M$59M+4.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ecor1 Capital, LLC’s full portfolio or all institutional holders of RNAGBP.